RYAN KELLEY: Open Payments
NPI 1346855517 · THIBODAUX, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,031 in 45 payments from 12 companies in 2025. Trend: 2023 $1,248 · 2024 $537 · 2025 $1,031
Food & beverage: $1,031
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 9 | $194 |
| Neurocrine BioSciences, Inc. | 5 | $163 |
| ABBVIE INC. | 5 | $117 |
| Janssen Pharmaceuticals, Inc | 4 | $102 |
| Teva Pharmaceuticals USA, Inc. | 5 | $101 |
| Lundbeck LLC | 5 | $89 |
| Vanda Pharmaceuticals Inc. | 3 | $76 |
| Corium, LLC | 3 | $73 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| E.R. Squibb & Sons, L.L.C. | 2 | $33 |
Products named: ARISTADA, INGREZZA, VRAYLAR, INVEGA, FANAPT, Azstarys, REXULTI, ABILIFY ASIMTUFII.
Industry payments across LA — which companies pay providers there.
